1[1]Antman EM,Anbe DT,Armstrong PW,et al.ACC/AHA guidelines for the management of patients with ST-elevation myocardialinfarction-executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)[J].Circulation,2004,110(5):588-636.
2[2]Sabatine MS,Cannon CP,Gibson CM,et al.Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation[J].N Engl J Med,2005,352(12):1179-1189.
3[3]De Luca G,Suryapranata H,Stone GW,et al.Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction:a meta-analysis of randomized trials[J].JAMA,2005,293(14):1759-1765.
4[4]Chen ZM,Pan HC,Chen YP.Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction:randomised placebo-controlled trial[J].Lancet,2005,366(9497):1622-1632.
5[5]Antman EM,Louwerenburg HW,Baars HF,et al.Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction:results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial[J].Circulation,2002,105 (14):1642-1649.
6[6]Yusuf S,Mehta SR,Xie C,et al.Effects of reviparin,a lowmolecular-weight heparin,on mortality,reinfarction,and strokes in patients with acute myocardial infarction presenting with ST-segment elevation[J].JAMA,2005,293 (4):427-435.
